From: Decreased response inhibition in middle-aged male patients with type 2 diabetes
 | OW patients | NW patients | OW controls | NW controls |
---|---|---|---|---|
N | 16 | 11 | 11 | 16 |
Age (years) | 42.9 ± 8.4 | 50.2 ± 7.1a, b | 37.0 ± 5.4a | 36.6 ± 7.9b |
   Range | 30-59 | 38-58 | 31-48 | 30-56 |
Education (years) | 15.9 ± 1.2 | 16.4 ± 1.3 | 16.6 ± 1.1 | 16.8 ± 1.3 |
BMI (kg/m2) | 29.8 ± 4.5c, d | 23.4 ± 1.3a, c | 27.6 ± 3.8a, e | 21.7 ± 1.4d, e |
Systolic blood pressure (mmHg) | 131.2 ± 9.9d | 129.6 ± 17.8b | 122.7 ± 11.2 | 114.2 ± 8.9b, d |
Diastolic blood pressure (mmHg) | 80.6 ± 11.3 | 78.6 ± 8.8 | 82.9 ± 13.2 | 74.8 ± 12.2 |
HbA1C (%) | 8.2 ± 1.6d, f | 7.6 ± 1.8a, b | 4.9 ± 0.2a, f | 4.8 ± 0.3b, d |
Plasma glucose (mmol/L) | 8.4 ± 2.2d, f | 7.6 ± 1.6a, b | 5.4 ± 0.3a, f | 5.3 ± 0.3b, d |
Plasma insulin (pmol/L) | 82.6 ± 70.1 | 44.4 ± 31.3 | 54.2 ± 7.6 | 55.6 ± 11.8 |
HOMA-IR | 4.6 ± 4.4d | 2.2 ± 1.7 | 1.9 ± 0.3 | 1.9 ± 0.4d |
Plasma leptin (ng/ml) | 7.14 ± 4.92c, d | 2.91 ± 1.47c | 5.41 ± 3.90 | 3.48 ± 1.55d |